Drugs / rgp120/HIV-1 SF-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00000749 | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rgp120/HIV-1 SF-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000749 ↗ |
| Modality | Vaccine | “200 mcg gp120 candidate vaccine” NCT00000749 ↗ |